Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-10T13:37:16.599Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of Cognitive Behaviour Therapy Via Mail for Cessation of Benzodiazepine Use: A Series of Case Reports

Published online by Cambridge University Press:  11 April 2013

Jannette M. Parr ,
David J. Kavanagh ,
Ross McD. Young ,
Barbara Stubbs  and
Nick Bradizza
Jannette M. Parr
Affiliation:
The University of Queensland, School of Medicine, Discipline of Psychiatry, Brisbane, Queensland, Australia
David J. Kavanagh*
Affiliation:
Institute of Health & Biomedical Innovation and School of Psychology & Counselling, Queensland University of Technology, Brisbane, Queensland, Australia
Ross McD. Young
Affiliation:
Faculty of Health Sciences, Queensland University of Technology, Brisbane, Queensland, Australia
Barbara Stubbs
Affiliation:
Queensland Health, Cairns Health Service District, Cairns, Queensland, Australia
Nick Bradizza
Affiliation:
Queensland Health, Cairns Health Service District, Cairns, Queensland, Australia
*
Address for correspondence: Professor David Kavanagh, Institute of Health & Biomedical Innovation, Queensland University of Technology, GPO Box 2434, Brisbane QLD 4001, Australia. Email: david.kavanagh@qut.edu.au
Get access

Abstract

Benzodiazepines are widely prescribed to manage sleep disorders, anxiety and muscular tension. While providing short-term relief, continued use induces tolerance and withdrawal, and in older users, increases the risk of falls. However, long-term prescription remains common, and effective interventions are not widely available. This study developed a self-managed cognitive behaviour therapy package for cessation of benzodiazepine use delivered to participants via mail (M-CBT) and trialled its effectiveness as an adjunct to a general practitioner (GP)-managed dose reduction schedule. In the pilot trial, participants were randomly assigned to GP management with immediate or delayed M-CBT. Significant recruitment and engagement problems were experienced, and only three participants were allocated to each condition. After immediate M-CBT, two participants ceased use, while none receiving delayed treatment reduced daily intake by more than 50%. Across the sample, doses at 12 months remained significantly lower than baseline, and qualitative feedback from participants was positive. While M-CBT may have promise, improved engagement of GPs and participants is needed for this approach to substantially impact on community-wide benzodiazepine use.

Keywords

benzodiazepinescorrespondencecognitive-behaviour therapygeneral practitionermailed interventionself-managed
Type
Standard Papers
Information
Behaviour Change , Volume 30 , Issue 2 , June 2013 , pp. 74 - 83
Copyright
Copyright © The Authors 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashton, H. (1987). Benzodiazepine withdrawal: Outcome in 50 patients. British Journal of Addiction, 82 (6), 665–671.CrossRefGoogle ScholarPubMed
Australian Bureau of Statistics. (1996). National health survey, first results, Australia, 1995. Canberra, Australia: Author.Google Scholar
Barker, M.J., Greenwood, K.M., Jackson, M., & Crowe, S.F. (2004) Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis. Archives of Clinical Neuropsychology, 19 (3), 437–454.CrossRefGoogle ScholarPubMed
Barter, G., & Cormack, M. (1996). The long-term use of benzodiazepines: Patients’ views, accounts and experiences. Family Practice, 13 (6), 491–497.CrossRefGoogle ScholarPubMed
Clarke, G., Kelleher, C., Hornbrook, M., Debar, L., Dickerson, J., & Gullion, C. (2009). Randomized effectiveness trial of an Internet, pure self-help, cognitive behavioral intervention for depressive symptoms in young adults. Cognitive Behavioral Therapy, 38 (4), 222–234.CrossRefGoogle ScholarPubMed
Cumming, R.G., & Le Couteur, D.G. (2003) Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs, 17 (11), 825–837.CrossRefGoogle ScholarPubMed
D'Zurilla, T. J., & Goldfried, M. R. (1971). Problem solving and behaviour modification. Journal of Abnormal Psychology, 78, 107–126.CrossRefGoogle Scholar
Department of Health and Ageing. (2010). Expenditure and prescriptions twelve months to 30 June 2010. Retrieved from http://www.health.gov.au/internet/main/publishing.nsf/Content/pbs-stats-pbexp-jun10Google Scholar
Ghosh, A., Marks, I.M., & Carr, A.C. (1988). Therapist contact and outcome of self-exposure treatment for phobias: A controlled study. British Journal of Psychiatry, 152, 234–238.CrossRefGoogle ScholarPubMed
Glasgow, R. E., & Rosen, G. M. (1978). Behavioral bibliotherapy: A review of self-help behavior therapy manuals. Psychological Bulletin, 85 (1), 1–23.CrossRefGoogle ScholarPubMed
Hallstrom, C., & Lader, M. (1981). Benzodiazepine withdrawal phenomena. International Pharmacopsychiatry, 16 (4), 235–244.CrossRefGoogle ScholarPubMed
Holbrook, A.M., Crowther, R., Lotter, A., Cheng, C., & King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162 (2), 225–233.Google ScholarPubMed
Iliffe, S., Curran, H.V., Collins, R., Yuen Kee, S.C., Fletcher, S., & Woods, B. (2004). Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: Findings from interviews with service users and providers. Aging & Mental Health, 8 (3), 242–248.CrossRefGoogle ScholarPubMed
Kavanagh, D., & Connolly, J.M. (2009) Mailed treatment to augment primary care for alcohol disorders: A randomised controlled trial. Drug and Alcohol Review, 28 (1), 73–80.CrossRefGoogle ScholarPubMed
Lader, M.H. (1983). Dependence on benzodiazepines. Journal of Clinical Psychiatry, 44 (4), 121–127.Google ScholarPubMed
Lader, M.H., Tylee, A., & Donoghue, J. (2009). Withdrawing benzodiazepines in primary care. CNS Drugs, 23 (1), 19–34.CrossRefGoogle ScholarPubMed
Leipzig, R.M., Cumming, R.G., & Tinetti, M.E. (1999) Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs. Journal of the American Geriatrics Society, 47 (1), 30–39.CrossRefGoogle ScholarPubMed
Lidren, D.M., Watkins, P. L., Gould, R.A., Clum, G.A., Asterino, M., & Tulloch, H.L. (1994). A comparison of bibliotherapy and group therapy in the treatment of panic disorder. Journal of Consulting and Clinical Psychology, 62 (4), 865–869.CrossRefGoogle ScholarPubMed
MacKinnon, G.L., & Parker, W.A. (1982). Benzodiazepine withdrawal syndrome: A literature review and evaluation. The American Journal Of Drug and Alcohol Abuse, 9 (1), 19–33.CrossRefGoogle ScholarPubMed
Marlatt, G.A., & George, W.H. (1984). Relapse prevention: Introduction and overview of the model. Addiction Biology, 79 (3), 261–273.Google ScholarPubMed
Martin, J.L., Sainz-Pardo, M., Furukawa, T.A., Martin-Sanchez, E., Seoane, T., & Galan, C. (2007). Benzodiazepines in generalized anxiety disorder: Heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Journal of Psychopharmacology, 21 (7), 774–782.CrossRefGoogle ScholarPubMed
Miller, W.R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: The Guilford Press.Google Scholar
Olkkola, K.T., & Ahonen, J. (2008). Midazolam and other benzodiazepines. Handbook of Experimental Pharmacology (182), 335–360.CrossRefGoogle Scholar
Oude Voshaar, R.C., Couvee, J.E., van Balkom, A.J., Mulder, P.G., & Zitman, F.G. (2006). Strategies for discontinuing long-term benzodiazepine use: Meta-analysis. British Journal of Psychiatry, 189, 213–220.CrossRefGoogle Scholar
Parr, J.M., Kavanagh, D.J., Cahill, L., Mitchell, G., & Young, R.M. (2009). Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction, 104 (1), 13–24.CrossRefGoogle ScholarPubMed
Parr, J.M., Kavanagh, D.J., & Young, R.M. (2011). Acceptability of CBT via the internet for cessation benzodiazepine use. Drug and Alcohol Review, 30, 306–314.CrossRefGoogle Scholar
Parr, J.M., Kavanagh, D.J., Young, R.M., & McCafferty, K. (2006). Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis. Social Science and Medicine, 62 (5), 1237–1249.CrossRefGoogle ScholarPubMed
Petursson, H., & Lader, M.H. (1981). Withdrawal from long-term benzodiazepine treatment. British Medical Journal, 283 (6292), 643–645.CrossRefGoogle ScholarPubMed
Ray, W.A., Griffin, M.R., & Downey, W. (1989) Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association, 262 (23), 3303–3307.CrossRefGoogle ScholarPubMed
Ray, W.A., Griffin, M.R., Schaffner, W., Baugh, D.K., & Melton, L.J.3rd. (1987) Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine, 316 (7), 363–369.CrossRefGoogle ScholarPubMed
Ray, W.A., Thapa, P.B., & Gideon, P. (2000) Benzodiazepines and the risk of falls in nursing home residents. Journal of the American Geriatrics Society, 48 (6), 682–685.CrossRefGoogle ScholarPubMed
Sitharthan, T., Kavanagh, D.J., & Sayer, G. (1996). Moderating drinking by correspondence: An evaluation of a new method of intervention. Addiction, 91 (3), 345–355.CrossRefGoogle ScholarPubMed
Tranquiliser Recovery and New Existence. (2004). Benzodiazepine reduction guidelines for doctors. Melbourne, Australia: Author.Google Scholar
Tyrer, P. (1980). Dependence on benzodiazepines. British Journal of Psychiatry, 137, 576–577.CrossRefGoogle ScholarPubMed
Vicens, C., Fiol, F., Llobera, J., Campoamor, F., Mateu, C., Alegret, S., & Socías, I. (2006). Withdrawal from long-term benzodiazepine use: Randomised trial in family practice. British Journal of General Practice, 56 (533), 958–963.Google ScholarPubMed
Wagner, A.K., Zhang, F., Soumerai, S.B., Walker, A.M., Gurwitz, J.H., Glynn, R.J., & Ross-Degnan, D. (2004). Benzodiazepine use and hip fractures in the elderly: Who is at greatest risk? Archives of Internal Medicine, 164 (14), 1567–1572.CrossRefGoogle ScholarPubMed